Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
SGN | there is light! | 03/06/16 | 3 | 4.5K | |||
|
|||||||
SGN | Ann: Results of Annual General Meeting-SGN.AX | 25/05/16 | 0 | 1.3K | |||
|
|||||||
SGN | Ann: WPP AUNZ announces new leadership roles-SGN.AX | 25/05/16 | 0 | 1.3K | |||
|
|||||||
SGN | Ann: Annual General Meeting-SGN.AX | 25/05/16 | 0 | 1.2K | |||
|
|||||||
SGN | ASX 200 Query | 05/05/16 | 0 | 1.1K | |||
|
|||||||
SGN | Ann: Notice of Annual General Meeting/Proxy Form-SGN.AX | 02/05/16 | 0 | 974 | |||
|
|||||||
SGN | Ann: Amendment to Annexure B Ceasing to be a s/s holder notice-SGN.AX | 18/04/16 | 0 | 1.0K | |||
|
|||||||
SGN | Ann: Ceasing to be a substantial holder-SGN.AX | 13/04/16 | 0 | 959 | |||
|
See All Discussions